Silo Pharma Raises About $815,000 in Private Placement at $1.50 Per Share
Silo Pharma raised $815,000 in a private placement, issuing 136,005 shares at $1.50 each and pre-funded warrants for 430,661 shares at $1.4999 per warrant. Proceeds will fund working capital and corporate purposes, with the transaction closing on November 6, 2026.
How this was made
The 30-second read
Why it matters
The capital raise provides immediate working capital but may dilute existing shareholders; the market may view it as a stabilizing move for a micro‑cap biotech.
Market read
A modest, first‑report capital raise for a micro‑cap biotech; limited trading relevance beyond the ticker.
What to watch
Potential future dilution if additional capital is needed; warrant terms allow near‑free conversion.
Background
Silo Pharma filed an 8‑K reporting a private placement of common shares and pre‑funded warrants to accredited investors.
Ticker impact
Silo Pharma disclosed a private placement raising about $815,000, providing new capital for working purposes.
likely slight upward pressure as the market prices in the capital raise and improved liquidity
Micro‑cap raises of this size typically have limited immediate price effect but can stabilize the share price.
Market effects
Minimal impact on the broader biotech sector; similar small‑cap financing events are routine.
Limited to U.S. micro‑cap investors; no broader regional effect.
Low global relevance.
Counterpoint
The raise could signal cash constraints, suggesting caution despite the liquidity boost.
Key entities
- companySilo Pharma Inc.
Biotech company issuing the private placement.
